Standard Biotools (LAB) EBIT Growth (3y) (2013 - 2026)
Standard Biotools (LAB) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.37 Bn | 193.76 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 127.75 Bn | 124.27 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 119.07 Bn | 109.85 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.64 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.90 Bn | 31.79 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 13.06% |
| 10 | Standard Biotools | 252.70 Mn | -224.01 Mn | 10.54 Mn | -13.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -13.31% |
| Mar 31, 2026 | 9.02% |
| Dec 31, 2025 | -5.29% |
| Sep 30, 2025 | -4.30% |
| Jun 30, 2025 | 12.66% |
| Mar 31, 2025 | 0.65% |
| Sep 30, 2024 | 21.97% |
| Jun 30, 2024 | 6.13% |
| Mar 31, 2024 | -46.04% |
| Dec 31, 2023 | -8.16% |
| Sep 30, 2023 | -57.07% |
| Jun 30, 2023 | -8.33% |
| Mar 31, 2023 | -3.56% |
| Dec 31, 2022 | -31.99% |
| Sep 30, 2022 | -28.08% |
| Jun 30, 2022 | -38.12% |
| Mar 31, 2022 | -24.63% |
| Sep 30, 2021 | -69.07% |
| Jun 30, 2021 | -41.98% |
| Mar 31, 2021 | -15.21% |